Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13718-13727
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13718
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13718
Table 3 Meta-analyses of adjuvant chemotherapy after 2006
| Author | Year | Number of trials included | Number of patients | HR for OS | P value |
| GASTRIC | 2010 | 17 | 3838 | HR = 0.82 [0.76-0.90] | < 0.001 |
| Sun et al | 2009 | 12 | 3809 | HR = 0.78 [0.71-0.85] | < 0.001 |
| Zhao et al | 2008 | 15 | 3212 | RR = 0.88 [0.77-0.99] | 0.001 |
| Liu et al | 2008 | 19 | 4599 | RR = 0.85 [0.80-0.90] | < 0.00001 |
- Citation: Foo M, Leong T. Adjuvant therapy for gastric cancer: Current and future directions. World J Gastroenterol 2014; 20(38): 13718-13727
- URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13718.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13718